European Medicines Agency (EMEA) And US Food And Drug Administration (FDA) Extend Drug-label Based On Results Of The (Medical News Today)
Published by Yahoo! News Search Results for Food and Drug Admin October 22nd, 2006 in Yahoo FDA News, Regulatory AffairsIn its September meeting 2006, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) gave a positive opinion to include the use of docetaxel in combination with the current standard treatment - cisplatin and 5 - fluorouracil - for the induction treatment of patients with inoperable locally advanced squamous cell carcinoma of the head and neck. [click